1. Home
  2. CACI vs ITCI Comparison

CACI vs ITCI Comparison

Compare CACI & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • ITCI
  • Stock Information
  • Founded
  • CACI 1962
  • ITCI 2002
  • Country
  • CACI United States
  • ITCI United States
  • Employees
  • CACI N/A
  • ITCI N/A
  • Industry
  • CACI EDP Services
  • ITCI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CACI Technology
  • ITCI Health Care
  • Exchange
  • CACI Nasdaq
  • ITCI Nasdaq
  • Market Cap
  • CACI 11.4B
  • ITCI 8.0B
  • IPO Year
  • CACI 1979
  • ITCI N/A
  • Fundamental
  • Price
  • CACI $529.93
  • ITCI $78.68
  • Analyst Decision
  • CACI Buy
  • ITCI Strong Buy
  • Analyst Count
  • CACI 11
  • ITCI 12
  • Target Price
  • CACI $485.60
  • ITCI $97.00
  • AVG Volume (30 Days)
  • CACI 103.9K
  • ITCI 453.4K
  • Earning Date
  • CACI 10-23-2024
  • ITCI 10-30-2024
  • Dividend Yield
  • CACI N/A
  • ITCI N/A
  • EPS Growth
  • CACI 13.21
  • ITCI N/A
  • EPS
  • CACI 18.60
  • ITCI N/A
  • Revenue
  • CACI $7,659,832,000.00
  • ITCI $564,526,000.00
  • Revenue This Year
  • CACI $7.05
  • ITCI $46.60
  • Revenue Next Year
  • CACI $4.94
  • ITCI $37.06
  • P/E Ratio
  • CACI $28.48
  • ITCI N/A
  • Revenue Growth
  • CACI 14.28
  • ITCI 54.31
  • 52 Week Low
  • CACI $302.21
  • ITCI $45.50
  • 52 Week High
  • CACI $533.03
  • ITCI $84.89
  • Technical
  • Relative Strength Index (RSI)
  • CACI 75.61
  • ITCI 65.31
  • Support Level
  • CACI $525.21
  • ITCI $71.95
  • Resistance Level
  • CACI $532.74
  • ITCI $76.19
  • Average True Range (ATR)
  • CACI 6.21
  • ITCI 1.73
  • MACD
  • CACI 1.11
  • ITCI 0.54
  • Stochastic Oscillator
  • CACI 91.43
  • ITCI 98.05

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Share on Social Networks: